1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow CVI Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia 100 mg, 200 mg, 300 mg - Hyperlipidemia | Phase 2 | Unknown | CVI Pharmaceuticals | 200 | 2020-07-15 | 2020-06-23 |
Hyperlipidemias (1)
China (1)
Que Liu, MDPhD (1)